Exhibit/Partner

Become a Pharma Program Partner

At CASSS, we bring together industry, regulatory, and academic professionals to engage in critical discussions to solve technical and regulatory challenges in the field of biopharmaceutical development. We understand the value of partnerships and recognize collaboration and support are essential to program quality, attendee interactions, and series continuity. You, members of the biopharmaceutical industry, are invited to become a prominent Pharma Program Partner. As a program partner, you are a critical part of CASSS’ success. Whether your company is interested in a single meeting or a year-round commitment, we have various levels and packages to fit your recognition goals. Heighten your industry visibility today! 

Contact info@casss.org for more details.

 

Exhibitor Opportunities

For more information, please contact exhibits@casss.org.

View the Exhibitor Guidelines      View the Exhibitor Prospectus     Register Now  

 

Basic Tabletop w/ 2 Badges

$3,995.00

Tabletop Power

$250.00

15-Minute Pre-Record Vendor Showcase

$795.00

30-Minute Pre-Record Technical Seminar

$1,395.00

Extra Badges

$1,200.00

Email Spotlight

$600.00
Lanyards

SOLD OUT
Pens

$600.00

Product Literature Inserts

$600.00

Promotional PDF

$500.00

Pre-Conference Webinar
Contact Exhibitor Manager

 

Code of Conduct

CASSS is committed to providing a safe, productive, and welcoming environment for all meeting participants and CASSS staff. All participants, including, but not limited to, attendees, speakers, volunteers, industry, partners, exhibitors, CASSS staff members, service providers, and all others are expected to abide by this Code of Conduct.

View Code of Conduct

Join the CASSS Network

Join the community discussion and network with other professionals from industry, academia, and regulatory agencies.

LinkedIn  LinkedIn Group 

Facebook  X  YouTube

"A great opportunity to connect with peers and exhibitors, good for improving bioassay understanding for staff new to potency and clinical development stage."
Barbara Hebeis, Bioassays 2023 Attendee